Related Experiment Videos
Limiting and repairing the damage in multiple sclerosis
1University of Cambridge Clinical School, United Kingdom.
Schweizerische Medizinische Wochenschrift
|June 5, 1993
Summary
Treatments targeting brain inflammation and lymphocyte entry show promise for neurological diseases. Future therapies may combine anti-inflammatory strategies with glial progenitor support for myelin repair.
Area of Science:
- Neuroimmunology
- Neuroinflammation
- Demyelinating Diseases
Background:
- Brain inflammation involves lymphocyte migration across the blood-brain barrier, releasing immune mediators.
- Microglia interact with the oligodendrocyte-myelin unit, causing damage via tumor necrosis factor release.
- Disability in these diseases stems from inflammation and impaired remyelination by precursor cells.
Purpose of the Study:
- To explore therapeutic strategies for inflammatory brain diseases.
- To identify opportunities for treating demyelination and promoting myelin repair.
Main Methods:
- Review of mechanisms underlying brain inflammation and demyelination.
- Analysis of therapeutic targets including lymphocyte trafficking and glial progenitor cells.
Main Results:
- Limiting circulating lymphocytes or their CNS entry impacts inflammatory brain diseases.
- Targeting the interaction between microglia and myelin offers therapeutic potential.
- Successful repair requires addressing inflammation and supporting glial progenitor differentiation and myelination.
Conclusions:
- Future treatments for demyelinated lesions will likely involve a multi-pronged approach.
- This approach includes limiting inflammation, enhancing glial progenitor availability, and optimizing their growth factor environment.